On the origin of plasmid-borne, extended-spectrum, antibiotic resistance mutations in bacteria
- PMID: 9533872
- DOI: 10.1006/jtbi.1997.0563
On the origin of plasmid-borne, extended-spectrum, antibiotic resistance mutations in bacteria
Abstract
Many antibiotic resistance mutations arise in pathogenic bacteria that harbor plasmids (R-plasmids). Resistance to third generation cephalosporins, for instance, largely occurs by one or more point mutations in plasmid bla genes that expand the resistance spectrum of beta-lactamases. Here I review relevant evidence underlying the worldwide emergence of extended spectrum beta-lactamases (ESBLs). The conclusion reached is that the origin of these resistance-conferring mutations cannot be explained by a series of single point mutation and selection events. Instead, highly advantageous stochastic processes might exist that generate alterations in the sequence or the conformation of particular regions in chromosomal or plasmid genomes such as bla, i.e., recombination or mutation. Several explanations for the origin of ESBLs are reviewed but direct experimental evidence to support or to invalidate them is still lacking. The cellular conditions under which ESBLs arise are unknown; however, involvement of nutritional stresses inside natural animal hosts and of plasmid conjugal functions appear likely.
Copyright 1998 Academic Press Limited.
Similar articles
-
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].Acta Med Croatica. 2004;58(4):307-12. Acta Med Croatica. 2004. PMID: 15700687 Croatian.
-
Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).Acta Microbiol Immunol Hung. 1997;44(4):309-25. Acta Microbiol Immunol Hung. 1997. PMID: 9554165 Review.
-
[Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].Lijec Vjesn. 2004 Nov-Dec;126(11-12):314-24. Lijec Vjesn. 2004. PMID: 16082890 Review. Croatian.
-
Evolution of extended-spectrum beta-lactamases by mutation.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:11-32. doi: 10.1111/j.1469-0691.2007.01854.x. Clin Microbiol Infect. 2008. PMID: 18154525 Review.
-
What's new in antibiotic resistance? Focus on beta-lactamases.Drug Resist Updat. 2006 Jun;9(3):142-56. doi: 10.1016/j.drup.2006.05.005. Epub 2006 Aug 8. Drug Resist Updat. 2006. PMID: 16899402 Review.
Cited by
-
Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases.Antimicrob Agents Chemother. 2005 Nov;49(11):4754-6. doi: 10.1128/AAC.49.11.4754-4756.2005. Antimicrob Agents Chemother. 2005. PMID: 16251322 Free PMC article.
-
Antibiotic-resistant soil bacteria in transgenic plant fields.Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3957-62. doi: 10.1073/pnas.0800072105. Epub 2008 Feb 21. Proc Natl Acad Sci U S A. 2008. PMID: 18292221 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical